At the American Society of Clinical Oncology (ASCO) annual meeting, researchers reported on a trial in progress that hopes to prove that blocking the effects of adrenergic stress with propranolol, a ...

The clinical benefit of β blockade has been proven in a variety of pathologic settings, including hypertension, angina pectoris, acute- and post-myocardial infarction, and congestive heart failure.

Reductions in violence are seen in individuals using Beta adrenergic-blocking agents (Beta-blockers) compared with periods that they are not taking the medication, a new study finds. If the findings ...